comparemela.com

Latest Breaking News On - National health laboratory service - Page 5 : comparemela.com

BioMarin to Present Innovative Pipeline at R&D Day on September 12th in New York

Live Audio Webcast to Begin at 8:00 a.m. Eastern Time SAN RAFAEL, Calif., Sept. 11, 2023 /PRNewswire/  BioMarin Pharmaceutical Inc. , a global biotechnology company dedicated to transforming.

Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS)

In a population based cohort study, Eveline Klinkenberg and colleagues examine the impact of the PopART intervention on TB prevalence in Zambia and South Africa.

BioMarin to Present Pipeline at Upcoming R&D Day on Tuesday, September 12th

BioMarin Leadership and External Medical Experts to Discuss 7 Product Candidates in Clinical Development as well as ROCTAVIAN and VOXZOGO New Indication Opportunities R&D Day to be Webcast.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.